NANOBIOTIX (EGFF)
Sector: Hospital • Location: France
Source: European Investment Bank (EIB)
Financing the Borrower's planned expenditures in Research, Development and Innovation (RDI). The RDI expenditure programme will include the activities required to bring NBTXR3 (a nanoparticle radio-enhancer product) to the market, this will include the design and conduct of clinical trials. The development programme primarily targets indications in Soft Tissue Sarcomas, Head and Neck tumours and o
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | financed |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Financing the Borrower's planned expenditures in Research, Development and Innovation (RDI). The RDI expenditure programme will include the activities required to bring NBTXR3 (a nanoparticle radio-enhancer product) to the market, this will include the design and conduct of clinical trials. The development programme primarily targets indications in Soft Tissue Sarcomas, Head and Neck tumours and other solid tumours. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |